Andrew Lux - AtriCure Insider

ATRC -- USA Stock  

USD 29.70  0.38  1.30%

Dr. Andrew L. Lux, Ph.D., is Senior Vice President Operations and Quality of AtriCure Inc. Dr. Lux previously served as our Vice President and Chief Operating Officer from 2012 to 2013. Prior to joining AtriCure, Dr. Lux served in leadership capacities at both small and large companies. From 2010 to 2012, Dr. Lux served as the Senior Vice President of Manufacturing and Operations for IntriMed Technologies, a startup business focused on contract manufacturing of implantable medical devices. From 2008 to 2010, Dr. Lux was the Vice President of Research and Development, Operations and Service for WaterHealth International, Inc., a business focused on the water purificationdisinfections markets. From 2006 to 2008, Dr. Lux was the General Manager for Medtronic, Inc.s spinal division in Warsaw, Indiana, where he was responsible for the United States based manufacturing organization providing spinal implant and orthopedic instrumentation products. Prior to 2006, Dr. Lux served in a variety of executive capacities for medical device organizations including Baxter Healthcare, Inc., Medtronic, Inc., Johnson Johnson and General Electric Company
Age: 64  SVP Since 2013  MBA    
Lux received his M.S. and Ph.D. from M.I.T. and his M.B.A. from Case Western Reserve University.

Andrew Lux Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (6.72) % which means that it has lost $6.72 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (17.1) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 52.51 M in liabilities with Debt to Equity (D/E) ratio of 34.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AtriCure has Current Ratio of 3.09 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 2 records

SVP Since

Moshe CitronowiczBovie Medical Corporation
Susan LichtensteinHill Rom Holdings

Entity Summary

AtriCure, Inc. provides atrial fibrillation solutions to medical centers in the United States and internationally. The company was founded in 2000 and is headquartered in Mason, Ohio. AtriCure operates under Medical Instruments Supplies classification in USA and traded on BATS Exchange. It employs 570 people.AtriCure (ATRC) is traded on BATS Exchange in USA. It is located in OHIO U.S.A and employs 570 people. AtriCure is listed under Medical Equipment category by Fama And French industry classification.

AtriCure Leadership Team

Salvatore Privitera, CTO
Patricia Kennedy, Vice President General Manager - International
Andrew Lux, Sr. VP of Operations and Quality Assurance
Michael Hooven, Founder and Director
Karen Robards, Independent Director
Justin Noznesky, Senior Vice President Marketing and Business Development
Douglas Seith, COO
Andrew Wade, CFO, Senior Vice President
Regina Groves, Independent Director
Kristine Johnson, Independent Director
Scott Drake, Independent Director
Mark Collar, Independent Director
Michael Carrel, CEO and President and Director
Mark Lanning, Independent Director
Richard Johnston, Independent Chairman of the Board
Robert White, Independent Director
Sven Wehrwein, Independent Director
Elizabeth Krell, Independent Director

Stock Performance Indicators

Current Sentiment - ATRC

AtriCure Investor Sentiment
Most of Macroaxis users are presently bullish on AtriCure. What is your sentiment towards investing in AtriCure? Are you bullish or bearish?
98% Bullish
2% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for AtriCure and Ekso Bionics Holdings. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.